Company: VSA
Filing Date: 2025-11-13
Form Type: 424B5
Source: 0001213900-25-109735
Chunk: 12

Company: VisionSys AI Inc
Filing Date: 2025-11-13
Form: 424B5
Chunk 12
---
 proposed issuance of any ADSs, Ordinary Shares or Ordinary Share Equivalents or (2) file or cause to be filed any registration statement or amendment or supplement thereto, other than the this prospectus supplement or filing a registration statement on Form S-8 in connection with any employee benefit plan. |
| Risk factors           |     | Investing in our securities involves a high degree of risk. Before investing in our securities, you should carefully consider the risk factors described in the section titled “Risk Factors” beginning on page S-8 of this prospectus supplement as well as the risks identified in documents that are incorporated by reference in this prospectus supplement.                                                                                                                        |
| Depositary             |     | Citibank, N.A.                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Payment and settlement |     | The ADSs are expected to be delivered through the book-entry transfer facilities of The Depository Trust Company in New York, New York, and the Series A Warrants are expected to be delivered against payment, and the Placement Agent Warrants are expected to be delivered on or about November 13, 2025.                                                                                                                                                                            |

| * | 11,226,750,300 Class A ordinary shares outstanding before this offering is derived from                                              
 11,870,458,200 issued Class A ordinary shares as of the date of this prospectus supplement, excluding the 255,984,900 treasury Class 
 A ordinary shares and 387,723,000 Class A ordinary shares represented by treasury ADSs held by the Company.                          |

The number of ordinary shares that will be outstanding immediately after this offering is based upon:

| ● | 11,226,750,300                                                                                                                        
 Class A ordinary shares, and 360,302,950 Class B ordinary shares issued and outstanding as of the date of this prospectus supplement, 
 and                                                                                                                                   |

| ● | 9,230,750 ADSs represented by 2,307,687,500 Class A ordinary shares that we will issue and sell in this offering, and assuming no exercise of the Series 
 A Warrants or Placement Agent Warrants.                                                                                                                  |

Except as otherwise indicated, all information in this prospectus supplement assumes no exercise of the Series A Warrants and the Placement Agent Warrants pursuant to this offering.

<div align='center'>S-7

RISK FACTORS</div>

Investing in our securities involves a high degree of risk. Before you make a decision to invest in our securities, you should consider carefully the risks described below. You should